X3U-13762-70224
2 vaccinations
5 coded responses
26 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 017 / MA
- Registered
- 2022-08-20
- Relationship
- Child or adolescent in my care
- Guardian
- EML-57561-25329
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-20
Registered in v-safe
-
2022-08-20
Dose 1 — Moderna
- 2022-08-20
- 2022-08-21
-
2022-08-22
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Groin or underarm swelling/tenderness · NoneUnder 3 check-in
-
2022-08-23
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Groin or underarm swelling/tenderness · NoneUnder 3 check-in
-
2022-08-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Groin or underarm swelling/tenderness · NoneUnder 3 check-in
-
2022-08-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Groin or underarm swelling/tenderness · NoneUnder 3 check-in
- 2022-08-26
- 2022-08-27
- 2022-09-03
-
2022-09-10
Survey response — day 21, dose 1, under 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Currently have a non-covid coldMedDRA releases: 2024-11 · check-in free text available
- 2022-09-17
-
2022-09-24
Dose 2 — Moderna
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
-
2022-09-29
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Nasal congestion, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: FairFree text: Has a new cold (nasal congestion), negative COVID19 antigen testMedDRA releases: 2024-11 · check-in free text available
- 2022-09-30
- 2022-10-01
- 2022-10-08
-
2022-10-15
Survey response — day 21, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Worsened cough and runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-22
-
2022-10-29
Survey response — day 35, dose 2, under 3MedDRA: Otitis media acute, SARS-CoV-2 test negative, Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend schoolFree text: Multiple viral upper respiratory infections, 1 episode of unilateral acute otitis media, no wheezing/pneumonia/bronchiolitis. Negative COVID19 testing each time (antigen or PCR).MedDRA releases: 2024-11 · check-in free text available
- 2022-11-05
-
2022-12-24
Health check-in — 3 months, dose 2, under 3Feeling: Good · Be unable to work or attend schoolFree text: Febrile URI, not covidUnder 3 check-in · check-in free text available
-
2023-03-25
Survey response — 6 months, dose 2, under 3MedDRA: Ear infection, Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-20 | Moderna | No |
| 2 | 2022-09-24 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Currently have a non-covid cold
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Has a new cold (nasal congestion), negative COVID19 antigen test
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Worsened cough and runny nose
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Multiple viral upper respiratory infections, 1 episode of unilateral acute otitis media, no wheezing/pneumonia/bronchiolitis. Negative COVID19 testing each time (antigen or PCR).
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Febrile URI, not covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Otitis media acute | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release